Eli Lilly is building four new manufacturing sites, the drug company announced Wednesday, and though the $27 billion price tag is hefty, that’s not the notable piece of the announcement.

Eli Lilly and Company has announced plans to build four new pharmaceutical sites in the United States, according to a press release from Lilly. The positions are reported to be ‘high-wage.’ The ...

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...

With this latest announcement, Lilly has committed to investing more than $50 billion in U.S. manufacturing since 2020.

In a press release, Lilly chair and CEO David A. Ricks said, “Lilly's optimism about the potential of our pipeline across ...

Eli Lilly and Co. plans to bolster its domestic ... 10,000 construction jobs during development. “We are not just building facilities,” said Edgardo Hernandez, executive vice president and ...

The story has been updated to correct the new site locations At a press conference in Washington, D.C., Eli Lilly And Co (NYSE:LLY) announced its plans to bolster its domestic medicine production ...

Eli Lilly wants the most optimal locations to host its new manufacturing facilities in the U.S.—and it’s open to pitche | Eli ...

Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...